Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, giving promising developments across many healthcare and industrial apps. With its structural similarity to The natural way derived human serum albumin, OsrHSA gives a safer, more trustworthy alternative for therapeutic use, speciall